D
Predictmedix AI Inc.
PMEDF
$0.0319
$0.009542.41%
D
Sell
2/25/2025Upgraded
Predictmedix AI Inc. (PMEDF) was upgraded to D- from E+ on 2/25/2025 due to a noticeable increase in the valuation index and growth index. Operating cash flow increased 68.94% from -$16.1 to -$5, earnings per share increased from -$0.0013 to -$0.0012, and EBIT increased 6.38% from -$178.8 to -$167.4.
Predictmedix AI Inc. (PMEDF) was upgraded to D- from E+ on 2/25/2025 due to a noticeable increase in the valuation index and growth index. Operating cash flow increased 68.94% from -$16.1 to -$5, earnings per share increased from -$0.0013 to -$0.0012, and EBIT increased 6.38% from -$178.8 to -$167.4.
E
Sell
7/5/2023Downgrade
Predictmedix Inc. (PMEDF) was downgraded to E+ from D- on 7/5/2023 due to a noticeable decline in the solvency index, valuation index and growth index. Operating cash flow declined 1,079.44% from -$39.4 to -$464.7, debt to equity increased from -0.24 to 1.1, and the quick ratio declined from 0.14 to 0.12.
Predictmedix Inc. (PMEDF) was downgraded to E+ from D- on 7/5/2023 due to a noticeable decline in the solvency index, valuation index and growth index. Operating cash flow declined 1,079.44% from -$39.4 to -$464.7, debt to equity increased from -0.24 to 1.1, and the quick ratio declined from 0.14 to 0.12.
D
Sell
6/12/2023Upgraded
Predictmedix Inc. (PMEDF) was upgraded to D- from E+ on 6/12/2023 due to an increase in the valuation index, total return index and volatility index.
Predictmedix Inc. (PMEDF) was upgraded to D- from E+ on 6/12/2023 due to an increase in the valuation index, total return index and volatility index.
E
Sell
3/14/2023Downgrade
Predictmedix Inc. (PMEDF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the valuation index.
Predictmedix Inc. (PMEDF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the valuation index.
D
Sell
2/23/2023Upgraded
Predictmedix AI Inc. (PMEDF) was upgraded to D- from E+ on 02/23/2023.
Predictmedix AI Inc. (PMEDF) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
Predictmedix Inc. (PMEDF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 10,538.46% from -$2.6 to -$276.6, total revenue declined 36.59% from $4.1 to $2.6, and EBIT declined 25.3% from -$263.2 to -$329.8.
Predictmedix Inc. (PMEDF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 10,538.46% from -$2.6 to -$276.6, total revenue declined 36.59% from $4.1 to $2.6, and EBIT declined 25.3% from -$263.2 to -$329.8.
D
Sell
12/13/2022Downgrade
Predictmedix Inc. (PMEDF) was downgraded to D- from D on 12/13/2022 due to a major decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.83 to 0.77.
Predictmedix Inc. (PMEDF) was downgraded to D- from D on 12/13/2022 due to a major decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.83 to 0.77.
D
Sell
6/2/2022Upgraded
Predictmedix Inc. (PMEDF) was upgraded to D from D- on 6/2/2022 due to an increase in the volatility index, growth index and total return index. Operating cash flow increased 75.65% from -$471.1 to -$114.7.
Predictmedix Inc. (PMEDF) was upgraded to D from D- on 6/2/2022 due to an increase in the volatility index, growth index and total return index. Operating cash flow increased 75.65% from -$471.1 to -$114.7.
D
Sell
5/16/2022Upgraded
Predictmedix Inc. (PMEDF) was upgraded to D- from E+ on 5/16/2022 due to an increase in the total return index, volatility index and valuation index.
Predictmedix Inc. (PMEDF) was upgraded to D- from E+ on 5/16/2022 due to an increase in the total return index, volatility index and valuation index.
E
Sell
4/18/2022Downgrade
Predictmedix Inc. (PMEDF) was downgraded to E+ from D- on 4/18/2022 due to a major decline in the total return index.
Predictmedix Inc. (PMEDF) was downgraded to E+ from D- on 4/18/2022 due to a major decline in the total return index.
D
Sell
1/28/2022Downgrade
Predictmedix Inc. (PMEDF) was downgraded to D- from D on 1/28/2022 due to a large decline in the growth index, volatility index and total return index. Operating cash flow declined 54% from -$305.9 to -$471.1, earnings per share declined from -$0.0029 to -$0.0034, and EBIT declined 8.1% from -$291.5 to -$315.1.
Predictmedix Inc. (PMEDF) was downgraded to D- from D on 1/28/2022 due to a large decline in the growth index, volatility index and total return index. Operating cash flow declined 54% from -$305.9 to -$471.1, earnings per share declined from -$0.0029 to -$0.0034, and EBIT declined 8.1% from -$291.5 to -$315.1.
D
Sell
11/23/2021Upgraded
Predictmedix Inc. (PMEDF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index and total return index.
Predictmedix Inc. (PMEDF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index and total return index.
D
Sell
11/8/2021Downgrade
Predictmedix AI Inc. (PMEDF) was downgraded to D- from D on 11/08/2021.
Predictmedix AI Inc. (PMEDF) was downgraded to D- from D on 11/08/2021.
D
Sell
3/1/2021Upgraded
Predictmedix Inc. (PMEDF) was upgraded to D from D- on 3/1/2021 due to a large increase in the growth index. Operating cash flow increased 40.03% from -$312.3 to -$187.3.
Predictmedix Inc. (PMEDF) was upgraded to D from D- on 3/1/2021 due to a large increase in the growth index. Operating cash flow increased 40.03% from -$312.3 to -$187.3.
D
Sell
11/2/2020Upgraded
Predictmedix Inc. (PMEDF) was upgraded to D- from E on 11/2/2020 due to an increase in the valuation index.
Predictmedix Inc. (PMEDF) was upgraded to D- from E on 11/2/2020 due to an increase in the valuation index.
E
Sell
10/2/2020Downgrade
Predictmedix Inc. (PMEDF) was downgraded to E from E+ on 10/2/2020 due to a large decline in the volatility index, growth index and total return index. Earnings per share declined from $0.0001 to -$0.0035, operating cash flow declined 106% from -$151.6 to -$312.3, and EBIT declined 52.23% from -$221.7 to -$337.5.
Predictmedix Inc. (PMEDF) was downgraded to E from E+ on 10/2/2020 due to a large decline in the volatility index, growth index and total return index. Earnings per share declined from $0.0001 to -$0.0035, operating cash flow declined 106% from -$151.6 to -$312.3, and EBIT declined 52.23% from -$221.7 to -$337.5.
E
Sell
8/3/2020Upgraded
Predictmedix Inc. (PMEDF) was upgraded to E+ from E on 8/3/2020 due to a significant increase in the total return index and growth index. Earnings per share increased from -$0.0024 to $0.0001, and operating cash flow increased 25.9% from -$204.6 to -$151.6.
Predictmedix Inc. (PMEDF) was upgraded to E+ from E on 8/3/2020 due to a significant increase in the total return index and growth index. Earnings per share increased from -$0.0024 to $0.0001, and operating cash flow increased 25.9% from -$204.6 to -$151.6.
E
Sell
5/15/2020None
Predictmedix AI Inc. (PMEDF) was downgraded to E from U on 05/15/2020.
Predictmedix AI Inc. (PMEDF) was downgraded to E from U on 05/15/2020.
OTC PK
03/12/2025 10:00AM Eastern
Quotes delayed
